UNITED STATES PATENT AND TRADEMARK OFFICE
`
`UNITED STATES DEPARTMENT OF COMMERCE
`United States Patent and Trademark Office
`Address: COMMISSIONER FOR PATENTS
`P.O. Box 1450
`Alexandria, Virginia 22313-1450
`www .uspto.gov
`
`APPLICATION NO.
`
`FILING DATE
`
`FIRST NAMED INVENTOR
`
`ATTORNEY DOCKET NO.
`
`CONFIRMATION NO.
`
`13/901,437
`
`05/23/2013
`
`Giorgio Calderari
`
`23278.2.US.8
`
`8160
`
`07/16/2013
`7590
`53449
`PATENT CORRESPONDENCE
`ARNALL GOLDEN GREGORY LLP
`171 17TH STREET NW
`SUITE 2100
`ATLANTA, GA 30363
`
`EXAMINER
`
`GEMBEH, SHIRLEY V
`
`· ~I _____ AR_T_~--T----~---P-AP_E_R_NDMB
`____ E_R __ ~
`
`1628
`
`NOTIFICATION DATE
`
`DELIVERY MODE
`
`07/16/2013
`
`ELECTRONIC
`
`Please find below and/or attached an Office communication concerning this application or proceeding.
`
`The time pedod for reply, if any, is set in the attached communication.
`
`Notice of the Office communication was sent electronically on above-indicated "Notification Date" to the
`following e-mail address(es):
`patents@agg.com
`
`PTOL-90A (Rev. 04/07)
`
`Dr. Reddy’s Laboratories, Ltd., et al.
`v.
`Helsinn Healthcare S.A., et al.
`U.S. Patent No. 9,(cid:20)(cid:26)(cid:22),(cid:28)(cid:23)(cid:21)
`Reddy Exhibit 1018
`
`Exh. 1018
`
`

`
`Examiner-Initiated Interview Summary
`
`Application No.
`
`Applicant(s)
`
`13/901,437
`Examiner
`
`CALDERARI ET AL.
`Art Unit
`
`KATHLEEN K. BRAGDON
`
`1600
`
`All participants (applicant, applicant's representative, PTO personnel):
`
`(1) KATHLEEN K. BRAGDON.
`
`(2) CLARK SULLIVAN.
`
`(3) __ .
`
`(4) __ .
`
`Type:
`
`Date of Interview: 11 Julv 2013.
`[8J Telephonic 0 Video Conference
`0 Personal [copy given to: 0 applicant
`Exhibit shown or demonstration conducted: 0 Yes
`If Yes, brief description: __ .
`
`0 applicant's representative]
`1Z1 No.
`
`Issues Discussed 0101 0112 0102 0103 IZ!Others
`(For each of the checked box(es) above, please describe below the issue and detailed description of the discussion)
`
`Claim(s) discussed: n/a.
`
`Identification of prior art discussed: n/a.
`
`Substance of Interview
`(For each issue discussed, provide a detailed description and indicate if agreement was reached. Some topics may include: identification or clarification of a
`reference or a portion thereof, claim interpretation, proposed amendments, arguments of any applied references etc ... )
`
`Applicant called the undersigned to inquire about the notice received. mailed on 7/12/2013. in which the Office stated
`that the AlA status of the instant application was being changed to "No".
`
`Applicant explained that this assessment was incorrect because the instant application was filed as a CIP on
`5/23/2013. designated as a CIP in the ADS and designated as an AlA aplication in the ADS.
`
`The undersigned agreed with Applicant's assessment and has reset the AlA status to being AlA" Yes". The instant
`application will be examined as an AlA application.
`
`No further action is required bv Applicant.
`
`Applicant recordation instructions: It is not necessary for applicant to provide a separate record of the substance of interview.
`
`Examiner recordation instructions: Examiners must summarize the substance of any interview of record. A complete and proper recordation of
`the substance of an interview should include the items listed in MPEP 713.04 for complete and proper recordation including the identification of the
`general thrust of each argument or issue discussed, a general indication of any other pertinent matters discussed regarding patentability and the
`general results or outcome of the interview, to include an indication as to whether or not agreement was reached on the issues raised.
`0 Attachment
`
`/KATHLEEN K BRAGDON/
`Quality Assurance Specialist, TC 1600
`AlA FITF POC
`
`U.S. Patent and Trademark Off1ce
`PTOL·413B (Rev. 8/11/2010)
`
`Interview Summary
`
`Paper No. 20130711
`
`Exh. 1018